GlobeNewsWire
29 May 2026, 10:33 UTC · 15w ago
Verdict
Headline leans bearish. We score ADMA −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Culper Research alleges ADMA Biologics used a channel stuffing scheme to report 20% revenue growth in 2025 when real growth was actually -3%.
So whatAllegations of systemic financial fraud and artificial revenue inflation fundamentally undermine company valuation and trust.
More negative than 99% of claims this week
Law firm Bleichmar Fonti & Auld LLP has launched an investigation into ADMA Biologics for potential violations of federal securities laws.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 91% of claims this week
ADMA Biologics stock plummeted 29% over two trading days following the publication of the Culper Research report.
More negative than 80% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is being investigated for securities fraud and channel stuffing, resulting in a 29% stock price drop.
More negative than 69% of ticker scores this week
Mentioned in the context of a legal firm recovering $420 million from the company.
More negative than 69% of ticker scores this week
Mentioned in the context of a legal firm recovering $900 million from its Board of Directors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1d ago
+11.6%
Price is moving against the score
$8.85 vs $7.93 close before publication (May 28) · not market-adjusted
ADMA chart →
